Utility of Epstein-Barr Virus Biomarkers in Human Immunodeficiency Virus-related Lymphomas in the Modern Combined Antiretroviral Therapy Era

Clin Infect Dis. 2019 Feb 15;68(5):891-892. doi: 10.1093/cid/ciy786.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers
  • Epstein-Barr Virus Infections*
  • HIV
  • HIV Infections*
  • Herpesvirus 4, Human
  • Humans
  • Lymphoma*
  • Prognosis

Substances

  • Biomarkers